Related Experiment Video
Updated: Jun 25, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Current perioperative management of the patient with a cardiac rhythm management device
1Department of Anesthesiology, Mount Sinai School of Medicine, New York, NY, USA. marc.stone@mountsinai.org
Insights
Perioperative management of patients with cardiac rhythm management devices requires avoiding adverse outcomes and potential device reprogramming. Anesthesia practitioners must be familiar with current technology for safe patient care.
Area of Science:
- Anesthesiology
- Cardiology
- Biomedical Engineering
Background:
- Millions worldwide have cardiac rhythm management devices (pacemakers, implantable cardioverter-defibrillators).
- Perioperative management aims to prevent device damage and ensure proper function.
- Potential for device reprogramming is crucial for avoiding complications.
Purpose of the Study:
- To describe the current status of cardiac rhythm management devices.
- To discuss recommended perioperative management strategies for these patients.
Main Methods:
- Review of current cardiac rhythm management device technology.
- Discussion of perioperative management principles and recommendations.
Main Results:
- Safe management hinges on preventing device, lead, or implantation site damage.
- Reprogramming devices can prevent functional interruptions and inappropriate therapy.
- Anesthesia practitioners need to be familiar with device technology.
Conclusions:
- Understanding cardiac rhythm management devices is essential for anesthesia providers.
- Proactive perioperative management ensures patient safety and device efficacy.
- Familiarity with device technology and reprogramming is key to avoiding adverse events.
Abstract:
The safe and effective perioperative management of the patient with a cardiac rhythm management device (ie, pacemaker and/or implantable cardioverter defibrillator) is based entirely on the avoidance of adverse outcomes, including damage to the device, the leads, or the site of lead implantation that might prevent the device from functioning as intended. An important management principle is the potential reprogramming of such a device in the perioperative period to avoid transient interruption of device function or the delivery of inappropriate electrophysiological therapy (eg, unnecessary defibrillation or pacing). Given the large numbers of patients worldwide currently implanted with these devices, the anesthesia practitioner should become electively familiar with the current technology. This article describes the current status of cardiac rhythm management devices and discusses recommended perioperative management.
More Related Videos
08:42Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
07:39Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
Related Concept Videos
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmias VII: Nursing Management of Dysrhythmias
Cardiopulmonary Resuscitation IV: Pharmacological Management
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Cardiac Catheterization IV: Nursing Management